Date published:
PHI circular type:
Prescribed List announcement
Audience:
Health sector
The department has released the updated Prescribed List (PL) post-listing review framework (framework). The post-listing review capability was introduced as part of the PL Reforms. The framework provides a transparent approach to the post-listing review process and is used by the department to guide it’s conduct of post-listing reviews.
The framework outlines how the department:
- identifies devices that may be appropriate for a post-listing review
- prioritises devices identified as appropriate for a post-listing review
- determines the scope of a post-listing review
- undertakes a post-listing review
- informs and consults with stakeholders and sponsors during the post-listing review
- actions the outcomes and actions arising from a post-listing review.
The framework incorporates learnings from the pilot post-listing reviews stakeholders’ feedback. The department would like to thank all stakeholders for their input into the framework.
See more information on the pilot post-listing reviews.